EU’s Top Court Upholds Lundbeck Fines Over Pay-For-Delay Deals
Citalopram Agreements ‘Particularly Harmful To Competition’
Executive Summary
The CJEU found no error in a near decade-old decision by the European Commission that Lundbeck conspired with generic manufacturers to unlawfully delay competition to its antidepressant Celexa (citalopram).